References
- Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med 2012; 4:165rv13; PMID:23253612; https://doi.org/https://doi.org/10.1126/scitranslmed.3004404
- Sobel JD. Vulvovaginal candidosis. Lancet 2007; 369:1961-71; PMID:17560449; https://doi.org/https://doi.org/10.1016/S0140-6736(07)60917-9
- Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37:1612-8; PMID:19325476; https://doi.org/https://doi.org/10.1097/CCM.0b013e31819efac0
- Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 2007; 45:321-46; PMID:17510856; https://doi.org/https://doi.org/10.1080/13693780701218689
- Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004–2008. Diagn Microbiol Infect Dis 2012; 74:323-31; PMID:23102556; https://doi.org/https://doi.org/10.1016/j.diagmicrobio.2012.10.003
- Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 2010; 36:1-53; PMID:20088682; https://doi.org/https://doi.org/10.3109/10408410903241444
- Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis 2012; 73:45-8; PMID:22578938; https://doi.org/https://doi.org/10.1016/j.diagmicrobio.2012.02.001
- Moran C, Grussemeyer CA, Spalding JR, Benjamin DK, Jr, Reed SD. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am J Infect Control 2010; 38:78-80; PMID:19836856; https://doi.org/https://doi.org/10.1016/j.ajic.2009.06.014
- Quindos G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol 2014; 31:42-8; PMID:24270071; https://doi.org/https://doi.org/10.1016/j.riam.2013.10.001
- Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20:133-63; PMID:17223626; https://doi.org/https://doi.org/10.1128/CMR.00029-06
- Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, Bille J, Chang SC, da Luz Martins M, Duse A, et al. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance program. Diagn Microbiol Infect Dis 2010; 67:162-71; PMID:20338711; https://doi.org/https://doi.org/10.1016/j.diagmicrobio.2010.01.002
- Amorim-Vaz S, Delarze E, Ischer F, Sanglard D, Coste AT. Examining the virulence of Candida albicans transcription factor mutants using Galleria mellonella and mouse infection models. Front Microbiol 2015; 6:367; PMID:25999923; https://doi.org/https://doi.org/10.3389/fmicb.2015.00367
- Brunke S, Quintin J, Kasper L, Jacobsen ID, Richter ME, Hiller E, Schwarzmuller T, d'Enfert C, Kuchler K, Rupp S, et al. Of mice, flies–and men? Comparing fungal infection models for large-scale screening efforts. Dis Model Mech 2015; 8:473-86; PMID:25786415; https://doi.org/https://doi.org/10.1242/dmm.019901
- Chamilos G, Lionakis MS, Lewis RE, Kontoyiannis DP. Role of mini-host models in the study of medically important fungi. Lancet Infect Dis 2007; 7:42-55; PMID:17182343; https://doi.org/https://doi.org/10.1016/S1473-3099(06)70686-7
- Desalermos A, Fuchs BB, Mylonakis E. Selecting an invertebrate model host for the study of fungal pathogenesis. PLoS Pathog 2012; 8:e1002451; PMID:22319439; https://doi.org/https://doi.org/10.1371/journal.ppat.1002451
- Maccallum DM. Hosting infection: experimental models to assay Candida virulence. Int J Microbiol 2012; 2012:363764; PMID:22235206; https://doi.org/https://doi.org/10.1155/2012/363764
- Brennan M, Thomas DY, Whiteway M, Kavanagh K. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 2002; 34:153-7; PMID:12381467; https://doi.org/https://doi.org/10.1111/j.1574-695X.2002.tb00617.x
- Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol 2000; 27:163-9; PMID:10640612; https://doi.org/https://doi.org/10.1111/j.1574-695X.2000.tb01427.x
- Browne N, Heelan M, Kavanagh K. An analysis of the structural and functional similarities of insect hemocytes and mammalian phagocytes. Virulence 2013; 4:597-603; PMID:23921374; https://doi.org/https://doi.org/10.4161/viru.25906
- Gago S, Garcia-Rodas R, Cuesta I, Mellado E, Alastruey-Izquierdo A. Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella. Virulence 2014; 5:278-85; PMID:24193303; https://doi.org/https://doi.org/10.4161/viru.26973
- Mesa-Arango AC, Forastiero A, Bernal-Martinez L, Cuenca-Estrella M, Mellado E, Zaragoza O. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med Mycol 2013; 51:461-72; PMID:23170962; https://doi.org/https://doi.org/10.3109/13693786.2012.737031
- Scorzoni L, de Lucas MP, Mesa-Arango AC, Fusco-Almeida AM, Lozano E, Cuenca-Estrella M, Mendes-Giannini MJ, Zaragoza O. Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile. PLoS One 2013; 8:e60047; PMID:23555877; https://doi.org/https://doi.org/10.1371/journal.pone.0060047
- Jacobsen ID, Brunke S, Seider K, Schwarzmuller T, Firon A, d'Enfert C, Kuchler K, Hube B. Candida glabrata persistence in mice does not depend on host immunosuppression and is unaffected by fungal amino acid auxotrophy. Infect Immun 2010; 78:1066-77; PMID:20008535; https://doi.org/https://doi.org/10.1128/IAI.01244-09
- Bergin D, Brennan M, Kavanagh K. Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes Infect 2003; 5:1389-95; PMID:14670452; https://doi.org/https://doi.org/10.1016/j.micinf.2003.09.019
- Junqueira JC, Fuchs BB, Muhammed M, Coleman JJ, Suleiman JM, Vilela SF, Costa AC, Rasteiro VM, Jorge AO, Mylonakis E. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. BMC Microbiol 2011; 11:247; PMID:22053894; https://doi.org/https://doi.org/10.1186/1471-2180-11-247
- Borghi E, Andreoni S, Cirasola D, Ricucci V, Sciota R, Morace G. Antifungal resistance does not necessarily affect Candida glabrata fitness. J Chemother 2014; 26:32-6; PMID:24091025; https://doi.org/https://doi.org/10.1179/1973947813Y.0000000100
- Santos R, Costa C, Mil-Homens D, Romao D, de Carvalho CC, Pais P, Mira NP, Fialho AM, Teixeira MC. The multidrug resistance transporters CgTpo1_1 and CgTpo1_2 play a role in virulence and biofilm formation in the human pathogen Candida glabrata. Cell Microbiol 2016; 19:e12686; https://doi.org/https://doi.org/10.1111/cmi.12686
- Dujon B, Sherman D, Fischer G, Durrens P, Casaregola S, Lafontaine I, De Montigny J, Marck C, Neuveglise C, Talla E, et al. Genome evolution in yeasts. Nature 2004; 430:35-44; PMID:15229592; https://doi.org/https://doi.org/10.1038/nature02579
- Brand A, MacCallum DM, Brown AJ, Gow NA, Odds FC. Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell 2004; 3:900-9; PMID:15302823; https://doi.org/https://doi.org/10.1128/EC.3.4.900-909.2004
- Brunke S, Hube B. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol 2013; 15:701-8; PMID:23253282; https://doi.org/https://doi.org/10.1111/cmi.12091
- Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 2005; 73:3842-50; PMID:15972469; https://doi.org/https://doi.org/10.1128/IAI.73.7.3842-3850.2005
- Kavanagh K, Reeves EP. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol Rev 2004; 28:101-12; PMID:14975532; https://doi.org/https://doi.org/10.1016/j.femsre.2003.09.002
- Fuchs BB, O'Brien E, Khoury JB, Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 2010; 1:475-82; PMID:21178491; https://doi.org/https://doi.org/10.4161/viru.1.6.12985
- Cormack BP, Falkow S. Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata. Genetics 1999; 151:979-87; PMID:10049916
- Haynes KA, Westerneng TJ. Rapid identification of Candida albicans, C. glabrata, C. parapsilosis and C. krusei by species-specific PCR of large subunit ribosomal DNA. J Med Microbiol 1996; 44:390-6; PMID:8636954; https://doi.org/https://doi.org/10.1099/00222615-44-5-390
- Haynes KA, Westerneng TJ, Fell JW, Moens W. Rapid detection and identification of pathogenic fungi by polymerase chain reaction amplification of large subunit ribosomal DNA. J Med Vet Mycol 1995; 33:319-25; PMID:8544085; https://doi.org/https://doi.org/10.1080/02681219580000641
- Zhou PB, Thiele DJ. Isolation of a metal-activated transcription factor gene from Candida glabrata by complementation in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 1991; 88:6112-6; PMID:2068090; https://doi.org/https://doi.org/10.1073/pnas.88.14.6112
- Reding-Roman C, Hewlett M, Duxbury S, Gori F, Gudelj I, Beardmore R. The unconstrained evolution of fast and efficient antibiotic-resistant bacterial genomes. Nat Ecol Evol 2017; 1:0050; https://doi.org/https://doi.org/10.1038/s41559-016-0050
- Staab JF, Sundstrom P. URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes. Trends Microbiol 2003; 11:69-73; PMID:12598128; https://doi.org/https://doi.org/10.1016/S0966-842X(02)00029-X
- Kitada K, Yamaguchi E, Arisawa M. Cloning of the Candida glabrata TRP1 and HIS3 genes, and construction of their disruptant strains by sequential integrative transformation. Gene 1995; 165:203-6; PMID:8522176; https://doi.org/https://doi.org/10.1016/0378-1119(95)00552-H
- Schwarzmuller T, Ma B, Hiller E, Istel F, Tscherner M, Brunke S, Ames L, Firon A, Green B, Cabral V, et al. Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes. PLoS Pathog 2014; 10:e1004211; PMID:24945925; https://doi.org/https://doi.org/10.1371/journal.ppat.1004211
- Roetzer A, Klopf E, Gratz N, Marcet-Houben M, Hiller E, Rupp S, Gabaldon T, Kovarik P, Schuller C. Regulation of Candida glabrata oxidative stress resistance is adapted to host environment. FEBS Lett 2011; 585:319-27; PMID:21156173; https://doi.org/https://doi.org/10.1016/j.febslet.2010.12.006
- Weig M, Haynes K, Rogers TR, Kurzai O, Frosch M, Muhlschlegel FA. A GAS-like gene family in the pathogenic fungus Candida glabrata. Microbiology 2001; 147:2007-19; PMID:11495979; https://doi.org/https://doi.org/10.1099/00221287-147-8-2007
- West L, Lowman DW, Mora-Montes HM, Grubb S, Murdoch C, Thornhill MH, Gow NA, Williams D, Haynes K. Differential virulence of Candida glabrata glycosylation mutants. J Biol Chem 2013; 288:22006-18; PMID:23720756; https://doi.org/https://doi.org/10.1074/jbc.M113.478743
- Calcagno AM, Bignell E, Rogers TR, Canedo M, Muhlschlegel FA, Haynes K. Candida glabrata Ste20 is involved in maintaining cell wall integrity and adaptation to hypertonic stress, and is required for wild-type levels of virulence. Yeast 2004; 21:557-68; PMID:15164359; https://doi.org/https://doi.org/10.1002/yea.1125
- Miyazaki T, Inamine T, Yamauchi S, Nagayoshi Y, Saijo T, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, et al. Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata. FEMS Yeast Res 2010; 10:343-52; PMID:20214686; https://doi.org/https://doi.org/10.1111/j.1567-1364.2010.00611.x
- Saijo T, Miyazaki T, Izumikawa K, Mihara T, Takazono T, Kosai K, Imamura Y, Seki M, Kakeya H, Yamamoto Y, et al. Skn7p is involved in oxidative stress response and virulence of Candida glabrata. Mycopathologia 2010; 169:81-90; PMID:19693686; https://doi.org/https://doi.org/10.1007/s11046-009-9233-5
- Srivastava VK, Suneetha KJ, Kaur R. The mitogen-activated protein kinase CgHog1 is required for iron homeostasis, adherence and virulence in Candida glabrata. FEBS J 2015; 282:2142-66; PMID:25772226; https://doi.org/https://doi.org/10.1111/febs.13264
- Chen KH, Miyazaki T, Tsai HF, Bennett JE. The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata. Gene 2007; 386:63-72; PMID:17046176; https://doi.org/https://doi.org/10.1016/j.gene.2006.08.010
- Cuellar-Cruz M, Briones-Martin-del-Campo M, Canas-Villamar I, Montalvo-Arredondo J, Riego-Ruiz L, Castano I, De Las Penas A. High resistance to oxidative stress in the fungal pathogen Candida glabrata is mediated by a single catalase, Cta1p, and is controlled by the transcription factors Yap1p, Skn7p, Msn2p, and Msn4p. Eukaryot Cell 2008; 7:814-25; PMID:18375620; https://doi.org/https://doi.org/10.1128/EC.00011-08
- Kelly J, Kavanagh K. Caspofungin primes the immune response of the larvae of Galleria mellonella and induces a non-specific antimicrobial response. J Med Microbiol 2011; 60:189-96; PMID:20947665; https://doi.org/https://doi.org/10.1099/jmm.0.025494-0
- Li DD, Deng L, Hu GH, Zhao LX, Hu DD, Jiang YY, Wang Y. Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents. Biol Pharm Bull 2013; 36:1482-7; PMID:23995660; https://doi.org/https://doi.org/10.1248/bpb.b13-00270